AVEO Pharmaceuticals (AVEO) Reports In-Line Q1 Loss of 77c/Share

AVEO Pharmaceuticals (NASDAQ: AVEO) reported Q1 EPS of ($0.77), in-line with the analyst estimate of ($0.77). Revenue for the quarter came in at $860 thousand versus the consensus estimate of $1.99 million.

For earnings history and earnings-related data on AVEO Pharmaceuticals (AVEO) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Traws Pharma (TRAW) Tops Q2 EPS by 27c
• Nuvve Holdin (NVVE) Misses Q2 EPS by 1445c